Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-bead agglutination

Anna B. Proietti, Mary Jo Johnson, Fernando A. Proietti, John Repke, William R. Bell

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Plasma and serum from pregnant women with preeclampsia (N = 35) and normotensive pregnant (N = 71) and nonpregnant (N = 10) controls were screened for fibrin(ogen) degradation products (fibrinogen and cross-linked fibrin degradation products, and fibrin polymers) using three different assay systems (immunoblot, enzyme-linked immunosorbent assay [ELISA], and latex-bead agglutination assay). All tests showed statistically significant differences (P < .05) between the preeclamptic patients and the other two groups (pregnant and nonpregnant women). The ELISA assay for total fibrin(ogen) degradation products was the most sensitive test, but was less specific than D-dimer latex. Eleven of the 35 preeclamptic women developed HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet counts). Positive tests were as common in the 11 preeclamptic women who developed the syndrome as in the 24 who did not. These results suggest that fibrinolytic disorders are secondary pathophysiologic events in the course of preeclampsia, but further studies with a larger number of patients are needed.

Original languageEnglish (US)
Pages (from-to)696-700
Number of pages5
JournalObstetrics and Gynecology
Volume77
Issue number5
StatePublished - Jan 1 1991

Fingerprint

Fibrin Fibrinogen Degradation Products
Agglutination
Pre-Eclampsia
Microspheres
Enzyme-Linked Immunosorbent Assay
Pregnant Women
HELLP Syndrome
Latex
Hemolysis
Fibrin
Platelet Count
Polymers
Liver
Enzymes
Serum
estropipate

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

Proietti, Anna B. ; Jo Johnson, Mary ; Proietti, Fernando A. ; Repke, John ; Bell, William R. / Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-bead agglutination. In: Obstetrics and Gynecology. 1991 ; Vol. 77, No. 5. pp. 696-700.
@article{243f9860c8ae4e93b64b7325ba1a376e,
title = "Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-bead agglutination",
abstract = "Plasma and serum from pregnant women with preeclampsia (N = 35) and normotensive pregnant (N = 71) and nonpregnant (N = 10) controls were screened for fibrin(ogen) degradation products (fibrinogen and cross-linked fibrin degradation products, and fibrin polymers) using three different assay systems (immunoblot, enzyme-linked immunosorbent assay [ELISA], and latex-bead agglutination assay). All tests showed statistically significant differences (P < .05) between the preeclamptic patients and the other two groups (pregnant and nonpregnant women). The ELISA assay for total fibrin(ogen) degradation products was the most sensitive test, but was less specific than D-dimer latex. Eleven of the 35 preeclamptic women developed HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet counts). Positive tests were as common in the 11 preeclamptic women who developed the syndrome as in the 24 who did not. These results suggest that fibrinolytic disorders are secondary pathophysiologic events in the course of preeclampsia, but further studies with a larger number of patients are needed.",
author = "Proietti, {Anna B.} and {Jo Johnson}, Mary and Proietti, {Fernando A.} and John Repke and Bell, {William R.}",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "77",
pages = "696--700",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-bead agglutination. / Proietti, Anna B.; Jo Johnson, Mary; Proietti, Fernando A.; Repke, John; Bell, William R.

In: Obstetrics and Gynecology, Vol. 77, No. 5, 01.01.1991, p. 696-700.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessment of fibrin(ogen) degradation products in preeclampsia using immunoblot, enzyme-linked immunosorbent assay, and latex-bead agglutination

AU - Proietti, Anna B.

AU - Jo Johnson, Mary

AU - Proietti, Fernando A.

AU - Repke, John

AU - Bell, William R.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Plasma and serum from pregnant women with preeclampsia (N = 35) and normotensive pregnant (N = 71) and nonpregnant (N = 10) controls were screened for fibrin(ogen) degradation products (fibrinogen and cross-linked fibrin degradation products, and fibrin polymers) using three different assay systems (immunoblot, enzyme-linked immunosorbent assay [ELISA], and latex-bead agglutination assay). All tests showed statistically significant differences (P < .05) between the preeclamptic patients and the other two groups (pregnant and nonpregnant women). The ELISA assay for total fibrin(ogen) degradation products was the most sensitive test, but was less specific than D-dimer latex. Eleven of the 35 preeclamptic women developed HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet counts). Positive tests were as common in the 11 preeclamptic women who developed the syndrome as in the 24 who did not. These results suggest that fibrinolytic disorders are secondary pathophysiologic events in the course of preeclampsia, but further studies with a larger number of patients are needed.

AB - Plasma and serum from pregnant women with preeclampsia (N = 35) and normotensive pregnant (N = 71) and nonpregnant (N = 10) controls were screened for fibrin(ogen) degradation products (fibrinogen and cross-linked fibrin degradation products, and fibrin polymers) using three different assay systems (immunoblot, enzyme-linked immunosorbent assay [ELISA], and latex-bead agglutination assay). All tests showed statistically significant differences (P < .05) between the preeclamptic patients and the other two groups (pregnant and nonpregnant women). The ELISA assay for total fibrin(ogen) degradation products was the most sensitive test, but was less specific than D-dimer latex. Eleven of the 35 preeclamptic women developed HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet counts). Positive tests were as common in the 11 preeclamptic women who developed the syndrome as in the 24 who did not. These results suggest that fibrinolytic disorders are secondary pathophysiologic events in the course of preeclampsia, but further studies with a larger number of patients are needed.

UR - http://www.scopus.com/inward/record.url?scp=0025735579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025735579&partnerID=8YFLogxK

M3 - Article

VL - 77

SP - 696

EP - 700

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 5

ER -